Loading insider details...
Beta
Latest Form 4 (Sep 21, 2026): Exercise/Conversion of 5,000 ELVN shares, $12.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Aug 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Jul 21, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Jun 22, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Jun 4, 2026 | Kura Oncology, Inc. (KURA) | Grant/Award | 35,000 | n/a |
| May 20, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Apr 22, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Mar 27, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 40,000 | $99.2K |
| Mar 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 5,000 | $12.4K |
| Mar 11, 2026 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 29,871 | $74.1K |